Back in 2016, hundreds of jobs were expected for a drug manufacturing plant in the town of Dunkirk. The plant was built but ...

Back in 2016, hundreds of jobs were expected for a drug manufacturing plant in the town of Dunkirk. The plant was built but it never opened and those jobs never came. A decade later, there’s talk ...

ImmunityBio closed the first quarter of 2026 with its strongest commercial performance to date, yet its stock price tells a different story. The disconnect highlights a massive bet by traders against ...

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's ...